K
v
ire
.com
←
Back
Night
Docs
Library
Review
…
Author
Michael S. Kinch
also known as Kinch, Kinch, Michael, Kinch, Michael S
Stony Brook Medicine · Stony Brook University · University College Dublin · University of North Carolina at Chapel Hill
About this author
Works
203
Cited by
11,092
h-index
56
i10
99
ORCID ↗
Top papers
An analysis of FDA-approved drugs: natural products and their derivatives
Eric Patridge, Peter C. Gareiss, Michael S. Kinch, et al.
·
2015
·
Drug Discovery Today
↗ 811
Activation of Rac1, RhoA, and Mitogen-Activated Protein Kinases Is Required for Ras Transformation
Roya Khosravi‐Far, Patricia A. Solski, Geoffrey Clark, et al.
·
1995
·
Molecular and Cellular Biology
↗ 676
OA
Integrin-mediated cell adhesion activates mitogen-activated protein kinases.
Qing Chen, Michael S. Kinch, Taichen Lin, et al.
·
1994
·
Journal of Biological Chemistry
↗ 655
OA
Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation
Hui Miao, Elisabeth Burnett, Michael S. Kinch, et al.
·
1999
·
Nature Cell Biology
↗ 548
EphA2 overexpression causes tumorigenesis of mammary epithelial cells.
Daniel P. Zelinski, Nicole D. Zantek, Jane C. Stewart, et al.
·
2001
·
PubMed
↗ 463
Tyrosine phosphorylation regulates the adhesions of ras-transformed breast epithelia.
Michael S. Kinch, Geoffrey Clark, Channing J. Der, et al.
·
1995
·
The Journal of Cell Biology
↗ 298
OA
Overexpression of the EphA2 tyrosine kinase in prostate cancer
Jennifer Walker‐Daniels, Karen Coffman, M. Azimi, et al.
·
1999
·
The Prostate
↗ 270
E-cadherin regulates the function of the EphA2 receptor tyrosine kinase.
Nicole D. Zantek, M. Azimi, Mary Fedor‐Chaiken, et al.
·
1999
·
PubMed
↗ 252
Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2).
Angela R. Hess, Elisabeth A. Seftor, L. M. Gardner, et al.
·
2001
·
PubMed
↗ 240
Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival.
Michael S. Kinch, Mary-Beth H Moore, David H. Harpole
·
2003
·
PubMed
↗ 239
EphA2 Expression Is Associated with Aggressive Features in Ovarian Carcinoma
Premal H. Thaker, Michael T. Deavers, Joseph Celestino, et al.
·
2004
·
Clinical Cancer Research
↗ 212
An overview of FDA-approved new molecular entities: 1827–2013
Michael S. Kinch, Austin Haynesworth, Sarah L. Kinch, et al.
·
2014
·
Drug Discovery Today
↗ 208
Books
Between hope and fear
2018
A Prescription for Change
2016
·
University of North Carolina Press